Cas no 1354017-20-1 (tert-butyl (3S)-3-bromopiperidine-1-carboxylate)
tert-butyl (3S)-3-bromopiperidine-1-carboxylate Chemical and Physical Properties
Names and Identifiers
-
- (S)-3-Bromo-piperidine-1-carboxylic acid tert-butyl ester
- tert-butyl (3S)-3-bromopiperidine-1-carboxylate
- (S)-tert-Butyl 3-bromopiperidine-1-carboxylate
- MFCD19105582
- 1-Boc-(S)-3-Bromopiperidine
- 1354017-20-1
- (S)-tert-Butyl3-bromopiperidine-1-carboxylate
- AKOS008901161
- BS-15231
- DB-362429
- CS-0183475
- (S)-1-Boc-3-bromopiperidine
- 899-019-2
-
- MDL: MFCD19105582
- Inchi: 1S/C10H18BrNO2/c1-10(2,3)14-9(13)12-6-4-5-8(11)7-12/h8H,4-7H2,1-3H3/t8-/m0/s1
- InChI Key: YCUDHDNCZHPAJK-QMMMGPOBSA-N
- SMILES: Br[C@@H]1CN(C(=O)OC(C)(C)C)CCC1
Computed Properties
- Exact Mass: 263.05209g/mol
- Monoisotopic Mass: 263.05209g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 14
- Rotatable Bond Count: 3
- Complexity: 213
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 1
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 2.4
- Topological Polar Surface Area: 29.5?2
tert-butyl (3S)-3-bromopiperidine-1-carboxylate Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Alichem | A129007303-250mg |
(S)-tert-Butyl 3-bromopiperidine-1-carboxylate |
1354017-20-1 | 95% | 250mg |
$427.68 | 2022-04-03 | |
| Alichem | A129007303-1g |
(S)-tert-Butyl 3-bromopiperidine-1-carboxylate |
1354017-20-1 | 95% | 1g |
$1,079.10 | 2022-04-03 | |
| Fluorochem | 087322-1g |
S)-3-Bromo-piperidine-1-carboxylic acid tert-butyl ester |
1354017-20-1 | 95% | 1g |
£945.00 | 2022-03-01 | |
| Chemenu | CM294451-1g |
(S)-tert-Butyl 3-bromopiperidine-1-carboxylate |
1354017-20-1 | 95% | 1g |
$926 | 2021-08-18 | |
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | S47860-100mg |
(S)-tert-Butyl 3-bromopiperidine-1-carboxylate |
1354017-20-1 | 95% | 100mg |
¥1608.0 | 2024-07-19 | |
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | S47860-250mg |
(S)-tert-Butyl 3-bromopiperidine-1-carboxylate |
1354017-20-1 | 95% | 250mg |
¥3032.0 | 2024-07-19 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-ZU704-250mg |
tert-butyl (3S)-3-bromopiperidine-1-carboxylate |
1354017-20-1 | 95% | 250mg |
5160CNY | 2021-05-08 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-ZU704-50mg |
tert-butyl (3S)-3-bromopiperidine-1-carboxylate |
1354017-20-1 | 95% | 50mg |
1291.0CNY | 2021-08-03 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-ZU704-200mg |
tert-butyl (3S)-3-bromopiperidine-1-carboxylate |
1354017-20-1 | 95% | 200mg |
2737.0CNY | 2021-08-04 | |
| abcr | AB548113-250 mg |
(S)-tert-Butyl 3-bromopiperidine-1-carboxylate; . |
1354017-20-1 | 250mg |
€728.80 | 2023-06-14 |
tert-butyl (3S)-3-bromopiperidine-1-carboxylate Related Literature
-
Christopher B. Rodell,Christopher B. Highley,Minna H. Chen,Neville N. Dusaj,Chao Wang,Lin Han,Jason A. Burdick Soft Matter, 2016,12, 7839-7847
-
Pavel Karásek,Jakub Grym,Michal Roth,Josef Planeta,Franti?ek Foret Lab Chip, 2015,15, 311-318
-
Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
-
N. Soin,D. Boyer,K. Prashanthi,S. Sharma,A. A. Narasimulu,J. Luo,T. H. Shah,E. Siores,T. Thundat Chem. Commun., 2015,51, 8257-8260
-
Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064
Additional information on tert-butyl (3S)-3-bromopiperidine-1-carboxylate
tert-butyl (3S)-3-bromopiperidine-1-carboxylate: A Comprehensive Overview
tert-butyl (3S)-3-bromopiperidine-1-carboxylate, with the CAS number 1354017-20-1, is a significant compound in the field of organic chemistry and drug discovery. This compound is a derivative of piperidine, a six-membered saturated heterocyclic amine, and is characterized by its unique stereochemistry and functional groups. The molecule features a tert-butyl ester group attached to the piperidine ring at the 1-position, along with a bromine atom at the 3-position in the S-configuration. This combination makes it a versatile building block for various chemical transformations and applications.
The synthesis of tert-butyl (3S)-3-bromopiperidine-1-carboxylate typically involves multi-step processes, including ring formation, functionalization, and stereochemical control. Recent advancements in asymmetric synthesis have enabled the efficient preparation of this compound with high enantiomeric purity. The use of chiral catalysts and enantioselective reactions has been pivotal in achieving the desired S-configuration at the 3-position of the piperidine ring.
In terms of chemical properties, tert-butyl (3S)-3-bromopiperidine-1-carboxylate exhibits stability under various reaction conditions, making it suitable for a wide range of applications. Its tert-butyl ester group provides protection for the carboxylic acid functionality, which is often utilized in subsequent reactions such as nucleophilic substitutions or eliminations. The bromine atom at the 3-position serves as an excellent leaving group, facilitating further transformations to introduce diverse substituents into the piperidine ring.
Recent studies have highlighted the potential of tert-butyl (3S)-3-bromopiperidine-1-carboxylate as a key intermediate in drug discovery programs. Its structural versatility allows for the exploration of various pharmacophores, making it a valuable asset in medicinal chemistry. For instance, derivatives of this compound have shown promise in targeting G-protein coupled receptors (GPCRs) and other therapeutic targets associated with neurodegenerative diseases and cancer.
The stereochemistry of (3S)-configuration plays a critical role in determining the biological activity of this compound. Stereoisomers often exhibit different pharmacokinetic profiles and binding affinities to target proteins. Therefore, precise control over the stereochemistry during synthesis is essential for optimizing drug candidates derived from this compound.
In addition to its role in drug discovery, tert-butyl (3S)-bromopiperidine-1-carboxylate has found applications in materials science and catalysis. Its ability to undergo various cyclization reactions makes it a useful precursor for constructing complex molecular architectures. Recent research has also explored its use as a chiral ligand in asymmetric catalysis, demonstrating its potential to facilitate enantioselective transformations in organic synthesis.
The importance of bromopiperidine derivatives in modern chemistry cannot be overstated. Their unique combination of structural flexibility and functional diversity continues to drive innovation across multiple disciplines. As research progresses, new applications and insights into the properties of compounds like tert-butyl (3S)-3-bromopiperidine-1-carboxylate are expected to emerge, further solidifying their role as indispensable tools in chemical research.
1354017-20-1 (tert-butyl (3S)-3-bromopiperidine-1-carboxylate) Related Products
- 1420816-48-3(Tert-Butyl 3-bromo-3-methylpiperidine-1-carboxylate)
- 180695-79-8(N-Boc-4-bromopiperidine)
- 849928-26-3(Tert-butyl 3-bromopiperidine-1-carboxylate)
- 1354000-03-5(tert-butyl (3R)-3-bromopiperidine-1-carboxylate)
- 1225276-07-2(tert-butyl 2-bromo-7-azaspiro[3.5]nonane-7-carboxylate)
- 569660-89-5((S)-tert-Butyl 3-bromopyrrolidine-1-carboxylate)
- 939793-16-5(Tert-butyl 3-bromopyrrolidine-1-carboxylate)
- 569660-97-5(tert-butyl (3R)-3-bromopyrrolidine-1-carboxylate)
- 889942-58-9(tert-Butyl 2-(bromomethyl)piperidine-1-carboxylate)
- 1420872-54-3(Tert-Butyl 2-(1-bromoethyl)piperidine-1-carboxylate)